Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Interventions
DRUG

Enteral nutrition

Patients in the Trial Group received concurrent chemoradiotherapy and standardized, whole-course enteral nutrition management.

RADIATION

radiotherapy

"Patients receive intensity modulated radiation therapy(IMRT) from week 1 to week 7,once a day, 5 times per week.~Radiotherapy dose:95% gross tumor volume(GTV-T) 60-66 Gy /30-33f,GTV-N 60-66 Gy /30-33f,CTV-T 50-54 Gy /25-27f,CTV-N 50-54 Gy /25-27f."

Trial Locations (1)

610041

Sichuan Cancer Hospital & Institute, Chengdu

All Listed Sponsors
collaborator

Wuhan University

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Shanxi Province Cancer Hospital

OTHER

collaborator

Shandong Tumor Hospital

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

Hebei Medical University Fourth Hospital

OTHER

lead

Sichuan Cancer Hospital and Research Institute

OTHER

NCT02399306 - Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma | Biotech Hunter | Biotech Hunter